CRISPR Therapeutics

CRSP

Börsenwert 4,1 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
276	276 IVC Wealth Advisors Silverdale, Pennsylvania	289.335 $	+13.177 $	+250	+5 %
277	277 HB Wealth Management Atlanta, Georgia	288.844 $	+279.141 $	+5.296	Neu
278	278 CAP Partners LLC Franklin, Tennessee	284.481 $	+48.228 $	+915	+21 %
279	279 Mitsubishi UFJ Asset Management Tokyo, Japan	283.281 $	+16.603 $	+315	+6 %
280	280 Integrated Wealth Concepts Waltham, Massachusetts	273.083 $	-2.425 $	-46	-0,9 %
281	PR 281 PSP Research Newtown Square, Pennsylvania	272.700 $	-237.186 $	-4.500	-47 %
282	282 LMR Partners London, United Kingdom	272.700 $	–	–	–
283	283 Pavaki Capital Management Pueblo, Colorado	272.700 $	–	–	–
284	284 Capital Advisors Inc Tulsa, Oklahoma	272.155 $	–	–	–
285	285 Kovack Advisors Ft. Lauderdale, Florida	269.396 $	+2.635 $	+50	+1 %
286	286 Sittner & Nelson Eugene, Oregon	261.847 $	-13.177 $	-250	-5 %
287	287 Capital Investment Advisory Services Raleigh, North Carolina	259.665 $	-240.453 $	-4.562	-49 %
288	288 Keynote Financial Services Vernon, Connecticut	259.501 $	+250.784 $	+4.758	Neu
289	289 Quadcap Wealth Management Frisco, Texas	258.902 $	-4.902 $	-93	-2 %
290	290 Ensign Peak Advisors Salt Lake City, Utah	254.375 $	-34.260 $	-650	-12 %
291	291 Meeder Advisory Services Dublin, Ohio	253.393 $	+20.029 $	+380	+9 %
292	292 North Star Asset Management Neenah, Wisconsin	246.793 $	–	–	–
293	293 Interchange Capital Partners Pittsburgh, Pennsylvania	245.321 $	-119.594 $	-2.269	-34 %
294	294 AlphaGrep UK London,	239.594 $	+231.546 $	+4.393	Neu
295	295 Neuberger Berman Group New York	238.122 $	+230.123 $	+4.366	Neu
296	296 Mirae Asset Global Investments Seoul, South Korea	235.286 $	-36.527 $	-693	-14 %
297	297 Cresset Asset Management Chicago, Illinois	232.265 $	–	–	–
298	298 Signature Wealth Management Partners Montvale, New Jersey	231.795 $	–	–	–
299	GA 299 GFS Advisors Houston, Texas	227.424 $	+791 $	+15	Neu
300	300 Quad-Cities Investment Group Davenport, Iowa	227.105 $	+219.476 $	+4.164	Neu

CRISPR Therapeutics CRSP Börsenwert 4,1 Mrd. $

CRISPR Therapeutics

CRSP

Börsenwert 4,1 Mrd. $